HEALTHIER CHOICES MANAGEMENT CORP.
10-Ks and 10-Qs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2019
Or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____
Commission file number: 001-36469
HEALTHIER CHOICES MANAGEMENT CORP.
(Exact name of Registrant as specified in its charter)
|
Delaware
|
84-1070932
|
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
|
incorporation or organization)
|
Identification No.)
|
|
|
3800 North 28
Th
Way
|
||
|
Hollywood, FL
|
33020
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: 305-600-5004
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
☒
Yes
☐
No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
☒
Yes
☐
No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller
reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☒
|
Smaller reporting company
|
☒
|
|
Emerging growth company
|
☐
|
||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
☐
Yes
☒
No
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
||
|
Common Stock, par value $0.0001 per share
|
HCMC
|
OTC Pink Marketplace
|
As of October 29, 2019, there were 67,698,494,241 shares of the registrant’s common stock, par value $0.0001 per share, outstanding.
TABLE OF CONTENTS
|
|
PAGE
|
PART I - FINANCIAL INFORMATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
|
September 30,
2019
|
December 31,
2018
|
||||
|
ASSETS
|
|||||
|
CURRENT ASSETS
|
|||||
|
Cash and cash equivalents
|
$
|
4,248,984
|
$
|
7,061,253
|
|
|
Accounts receivable, net
|
42,371
|
51,951
|
|||
|
Inventories
|
1,881,225
|
1,864,619
|
|||
|
Prepaid expenses and vendor deposits
|
306,274
|
402,578
|
|||
|
Investment
|
33,343
|
90,857
|
|||
|
Contract assets
|
18,000
|
32,400
|
|||
|
TOTAL CURRENT ASSETS
|
6,530,197
|
9,503,658
|
|||
|
Property and equipment, net of accumulated depreciation
|
353,681
|
497,039
|
|||
|
Intangible assets, net of accumulated amortization
|
2,029,610
|
3,062,204
|
|||
|
Goodwill
|
1,437,314
|
1,437,314
|
|||
|
Note receivable
|
390,757
|
528,007
|
|||
|
Right of use asset – operating lease, net
|
4,528,468
|
-
|
|||
|
Other assets
|
147,864
|
144,441
|
|||
|
TOTAL ASSETS
|
$
|
15,417,891
|
$
|
15,172,663
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||
|
CURRENT LIABILITIES
|
|||||
|
Accounts payable and accrued expenses
|
$
|
851,297
|
$
|
1,301,418
|
|
|
Contract liabilities
|
174,328
|
442,630
|
|||
|
Operating lease liability, current
|
472,106
|
-
|
|||
|
Loan payable, current
|
282,314
|
282,224
|
|||
|
Credit line
|
2,000,000
|
1,868,460
|
|||
|
Derivative liabilities – warrants
|
1,719,816
|
1,722,928
|
|||
|
TOTAL CURRENT LIABILITIES
|
5,499,861
|
5,617,660
|
|||
|
Loan payable, net of current portion
|
939,821
|
1,128,234
|
|||
|
Operating lease liability, net of current
|
3,474,665
|
-
|
|||
|
TOTAL LIABILITIES
|
9,914,347
|
6,745,894
|
|||
|
COMMITMENTS AND CONTINGENCIES (SEE NOTE 9)
|
|||||
|
STOCKHOLDERS’ EQUITY
|
|||||
|
Series B convertible preferred stock, $1,000 par value per share, 30,000 shares authorized; 20,150 shares
issued and outstanding as of September 30, 2019 and December 31, 2018; aggregate liquidation preference of $20.2 million
|
20,150,116
|
20,150,116
|
|||
|
Common Stock, $0.0001 par value per share, 750,000,000,000 shares authorized; 67,698,494,241 and
66,623,514,522 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively
|
6,769,849
|
6,662,351
|
|||
|
Additional paid-in capital
|
7,587,828
|
7,348,390
|
|||
|
Accumulated deficit
|
(29,004,249)
|
(25,734,088)
|
|||
|
TOTAL STOCKHOLDERS’ EQUITY
|
5,503,544
|
8,426,769
|
|||
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
15,417,891
|
$
|
15,172,663
|
|
See notes to unaudited condensed consolidated financial statements
1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
|
Three Months Ended
|
Nine Months Ended
|
||||||||||
|
September 30,
|
September 30,
|
||||||||||
|
2019
|
2018
|
2019
|
2018
|
||||||||
|
SALES
|
|||||||||||
|
Vapor sales, net
|
$
|
898,229
|
$
|
1,106,596
|
$
|
3,207,530
|
$
|
3,556,130
|
|||
|
Grocery sales, net
|
2,520,101
|
1,923,878
|
8,407,919
|
6,359,671
|
|||||||
|
TOTAL SALES, NET
|
3,418,330
|
3,030,474
|
11,615,449
|
9,915,801
|
|||||||
|
Cost of sales vapor
|
385,208
|
460,648
|
1,337,555
|
1,602,363
|
|||||||
|
Cost of sales grocery
|
1,629,980
|
1,183,033
|
5,309,567
|
3,850,998
|
|||||||
|
GROSS PROFIT
|
1,403,142
|
1,386,793
|
4,968,327
|
4,462,440
|
|||||||
|
OPERATING EXPENSES
|
2,532,505
|
2,179,492
|
8,057,452
|
7,334,165
|
|||||||
|
LOSS FROM OPERATIONS
|
(1,129,363)
|
(792,699)
|
(3,089,125)
|
(2,871,725)
|
|||||||
|
OTHER (EXPENSE) INCOME
|
|||||||||||
|
Gain (loss) on investment
|
(12,514)
|
11,999
|
(57,514)
|
11,999
|
|||||||
|
Other income (expense), net
|
(146)
|
152,260
|
(838)
|
469,760
|
|||||||
|
Interest income (expense), net
|
(8,280)
|
30,458
|
(19,669)
|
63,219
|
|||||||
|
Gain (loss) on repurchase of Series A warrants
|
-
|
(10,696,774)
|
-
|
(10,696,774)
|
|||||||
|
Total other (expense) income, net
|
(20,940)
|
(10,502,057)
|
(78,021)
|
(10,151,796)
|
|||||||
|
NET LOSS
|
$
|
(1,150,303)
|
$
|
(11,294,756)
|
$
|
(3,167,146)
|
$
|
(13,023,521)
|
|||
|
NET LOSS PER SHARE-BASIC AND DILUTED
|
$
|
0.00
|
$
|
0.00
|
$
|
0.00
|
$
|
0.00
|
|||
|
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-BASIC AND DILUTED
|
66,929,136,282
|
45,821,526,888
|
66,734,751,470
|
34,900,093,115
|
|||||||
See notes to unaudited condensed consolidated financial statements
2
CONDENSED CONSOLIDATED STOCKHOLDERS’ EQUITY STATEMENTS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019
(UNAUDITED)
|
Convertible
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Total
|
||||||||||||||
|
Balance – July 1, 2019
|
20,150
|
$
|
20,150,116
|
66,645,257,694
|
$
|
6,664,526
|
$
|
7,543,370
|
$
|
(27,853,946)
|
$
|
6,504,066
|
||||||||
|
Issuance of common stock in connection with cashless exercise of Series A warrants
|
-
|
-
|
53,236,547
|
5,323
|
(3,112)
|
-
|
2,211
|
|||||||||||||
|
Issuance of awarded stock for board members
|
-
|
-
|
1,000,000,000
|
100,000
|
(100,000)
|
-
|
-
|
|||||||||||||
|
Stock-based compensation expense
|
-
|
-
|
-
|
-
|
147,570
|
-
|
147,570
|
|||||||||||||
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
(1,150,303)
|
(1,150,303)
|
|||||||||||||
|
Balance – September 30, 2019
|
20,150
|
$
|
20,150,116
|
67,698,494,241
|
$
|
6,769,849
|
$
|
7,587,828
|
$
|
(29,004,249)
|
$
|
5,503,544
|
||||||||
HEALTHIER CHOICES MANAGEMENT CORP.
CONDENSED CONSOLIDATED STOCKHOLDERS’ EQUITY STATEMENTS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018
(UNAUDITED)
|
Convertible
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Total
|
||||||||||||||
|
Balance – July 1, 2018
|
-
|
$
|
-
|
29,348,867,108
|
$
|
2,934,887
|
$
|
11,238,744
|
$
|
(14,299,592)
|
$
|
(125,961)
|
||||||||
|
Issuance of common stock in connection with cashless exercise of Series A warrants
|
-
|
-
|
1,602,741,446
|
160,274
|
(93,958)
|
-
|
66,317
|
|||||||||||||
|
Stock options exercised
|
-
|
-
|
777,777,778
|
77,778
|
-
|
-
|
77,778
|
|||||||||||||
|
Issuance of preferred stock in connection with cashless exercise of Series A warrants
|
20,722
|
20,721,744
|
-
|
-
|
(1,692,747)
|
-
|
19,028,997
|
|||||||||||||
|
Modification of share-based payment awards to officers
|
-
|
-
|
19,000,000,000
|
1,900,000
|
(1,900,000)
|
-
|
-
|
|||||||||||||
|
Issuance of awarded stock for officers
|
-
|
-
|
3,000,000,000
|
300,000
|
(300,000)
|
-
|
-
|
|||||||||||||
|
Issuance of awarded stock for professional services
|
-
|
-
|
3,000,000,000
|
300,000
|
(300,000)
|
-
|
-
|
|||||||||||||
|
Preferred stock exercised
|
(572)
|
(571,628)
|
5,716,280,000
|
571,628
|
-
|
-
|
-
|
|||||||||||||
|
Stock swap
|
-
|
-
|
1,500,000,000
|
150,000
|
-
|
-
|
150,000
|
|||||||||||||
|
Stock-based compensation expense
|
-
|
-
|
-
|
-
|
140,356
|
-
|
140,356
|
|||||||||||||
|
Net loss
|
(11,294,756)
|
(11,294,756)
|
||||||||||||||||||
|
Balance – September 30, 2018
|
20,150
|
$
|
20,150,116
|
63,945,666,332
|
$
|
6,394,567
|
$
|
7,092,395
|
$
|
(25,594,348)
|
$
|
8,042,730
|
||||||||
See notes to unaudited condensed consolidated financial statements
3
CONDENSED CONSOLIDATED STOCKHOLDERS’ EQUITY STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019
(UNAUDITED)
|
Convertible
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Total
|
||||||||||||||
|
Balance – January 1, 2019
|
20,150
|
$
|
20,150,116
|
66,623,514,522
|
$
|
6,662,351
|
$
|
7,348,390
|
$
|
(25,734,088)
|
$
|
8,426,769
|
||||||||
|
Issuance of common stock in connection with cashless exercise of Series A warrants
|
-
|
-
|
74,979,719
|
7,498
|
(4,386)
|
-
|
3,112
|
|||||||||||||
|
Issuance of awarded stock for board members
|
-
|
-
|
1,000,000,000
|
100,000
|
(100,000)
|
-
|
-
|
|||||||||||||
|
Stock-based compensation expense
|
-
|
-
|
-
|
-
|
343,824
|
-
|
343,824
|
|||||||||||||
|
Cumulative Effect on adoption of ASC 842
|
-
|
-
|
-
|
-
|
-
|
(103,015)
|
(103,015)
|
|||||||||||||
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
(3,167,146)
|
(3,167,146)
|
|||||||||||||
|
Balance – September 30, 2019
|
20,150
|
$
|
20,150,116
|
67,698,494,241
|
$
|
6,769,849
|
$
|
7,587,828
|
$
|
(29,004,249)
|
$
|
5,503,544
|
||||||||
HEALTHIER CHOICES MANAGEMENT CORP.
CONDENSED CONSOLIDATED STOCKHOLDERS’ EQUITY STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018
(UNAUDITED)
|
Convertible
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Total
|
||||||||||||||
|
Balance – January 1, 2018
|
-
|
$
|
-
|
29,348,867,108
|
$
|
2,934,887
|
$
|
10,080,238
|
$
|
(12,570,827)
|
$
|
444,298
|
||||||||
|
Issuance of common stock in connection with cashless exercise of Series A warrants
|
-
|
-
|
1,602,741,446
|
160,274
|
(93,958)
|
-
|
66,317
|
|||||||||||||
|
Stock options exercised
|
-
|
-
|
777,777,778
|
77,778
|
-
|
-
|
77,778
|
|||||||||||||
|
Issuance of preferred stock in connection with cashless exercise of Series A warrants
|
20,722
|
20,721,744
|
-
|
-
|
(1,692,747)
|
-
|
19,028,997
|
|||||||||||||
|
Modification of share-based payment awards to officers
|
-
|
-
|
19,000,000,000
|
1,900,000
|
(1,900,000)
|
-
|
-
|
|||||||||||||
|
Issuance of awarded stock for officers
|
-
|
-
|
3,000,000,000
|
300,000
|
(300,000)
|
-
|
-
|
|||||||||||||
|
Issuance of awarded stock for professional services
|
-
|
-
|
3,000,000,000
|
300,000
|
(300,000)
|
-
|
-
|
|||||||||||||
|
Preferred stock exercised
|
(572)
|
(571,628)
|
5,716,280,000
|
571,628
|
-
|
-
|
-
|
|||||||||||||
|
Stock swap
|
-
|
-
|
1,500,000,000
|
150,000
|
-
|
-
|
150,000
|
|||||||||||||
|
Stock-based compensation expense
|
-
|
-
|
-
|
-
|
1,298,862
|
-
|
1,298,862
|
|||||||||||||
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
(13,023,521)
|
(13,023,521)
|
|||||||||||||
|
Balance – September 30, 2018
|
20,150
|
$
|
20,150,116
|
63,945,666,332
|
$
|
6,394,567
|
$
|
7,092,395
|
$
|
(25,594,348)
|
$
|
8,042,730
|
||||||||
See notes to unaudited condensed consolidated financial statements
4
HEALTHIER CHOICES MANAGEMENT CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
|
Nine Months Ended
September 30,
|
|||||
|
2019
|
2018
|
||||
|
OPERATING ACTIVITIES
|
|||||
|
Net loss
|
$
|
(3,167,146)
|
$
|
(13,023,521)
|
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|||||
|
Bad debt expense
|
(3,002)
|
(75,399)
|
|||
|
Depreciation and amortization
|
449,071
|
269,729
|
|||
|
Loss on disposal of assets
|
25,427
|
-
|
|||
|
Loss on investment
|
57,514
|
-
|
|||
|
Amortization of right-of-use asset
|
459,760
|
-
|
|||
|
Loss on repurchase of Series A warrants
|
-
|
10,696,774
|
|||
|
Stock-based compensation expense
|
343,824
|
1,298,862
|
|||
|
Changes in operating assets and liabilities:
|
|||||
|
Accounts receivable
|
12,582
|
21,036
|
|||
|
Inventories
|
(16,606)
|
(144,893)
|
|||
|
Prepaid expenses and vendor deposits
|
94,110
|
(288,359)
|
|||
|
Contract assets
|
14,400
|
(180,000)
|
|||
|
Other assets
|
(3,423)
|
-
|
|||
|
Accounts payable
|
(155,910)
|
(36,652)
|
|||
|
Accrued expenses
|
(294,211)
|
(112,343)
|
|||
|
Contract liabilities
|
(268,302)
|
1,968,682
|
|||
|
Lease liability
|
(402,857)
|
-
|
|||
|
NET CASH USED IN OPERATING ACTIVITIES
|
(2,854,769)
|
393,916
|
|||
|
INVESTING ACTIVITIES
|
|||||
|
Collection of note receivable
|
137,250
|
10,083
|
|||
|
Purchases of property and equipment
|
(12,967)
|
(42,520)
|
|||
|
Purchases of patent
|
(25,000)
|
(37,500)
|
|||
|
Gain on investment
|
-
|
(11,999)
|
|||
|
Issuance of note receivable
|
-
|
(500,000)
|
|||
|
NET CASH PROVIDED BY INVESTING ACTIVITIES
|
99,283
|
(581,936)
|
|||
|
FINANCING ACTIVITIES
|
|||||
|
Proceeds from line of credit
|
131,540
|
500,000
|
|||
|
Principal payments on loan payable
|
(188,323)
|
(1,573)
|
|||
|
Proceeds from exercise of stock options
|
-
|
77,778
|
|||
|
NET CASH PROVIDED BY FINANCING ACTIVITIES
|
(56,783)
|
576,205
|
|||
|
DECREASE IN CASH
|
(2,812,269)
|
388,185
|
|||
|
CASH AND CASH EQUIVALENTS — BEGINNING OF PERIOD
|
7,061,253
|
7,883,191
|
|||
|
CASH AND CASH EQUIVALENTS — END OF PERIOD
|
$
|
4,248,984
|
$
|
8,271,376
|
|
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
|
|||||
|
Cash paid for interest
|
$
|
107,646
|
$
|
1,750
|
|
See notes to unaudited condensed consolidated financial statements
5
Note 1. ORGANIZATION, GOING CONCERN, AND BASIS OF PRESENTATION
Organization
Healthier Choices Management Corp. (the “Company”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition
and other lifestyle alternatives. The Company currently operates nine retail vape stores in the Southeast region of the United States, through which it offers e-liquids, vaporizers and related products. The Company also operates Ada’s Natural Market,
a natural and organic grocery store, through its wholly owned subsidiary Healthy Choice Markets, Inc and Paradise Health and Nutrition, stores that offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli,
baked goods, dairy products, frozen foods, health & beauty products and natural household items through its wholly owned subsidiary Healthy Choice Markets 2, LLC. The Company also sells vitamins and supplements on the Amazon.com marketplace
through its wholly owned subsidiary Healthy U Wholesale, Inc. The Company markets the Q-Cup™ technology under the vape segment; this patented technology is based on a small, quartz cup called the Q-Cup™, which a customer partially fills with either
cannabis or CBD concentrate (approximately 50 mg) purchased from a third party. The Q-Cup™ is then inserted into the Q-Cup™ Tank or Globe, that heats the cup from the outside without coming in direct contact with the solid concentrate. This Q-Cup™
technology provides significantly more efficiency and an “on the go” solution for consumers who prefer to vape concentrates either medicinally or recreationally.
Liquidity
The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United
States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the
outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values.
The Company incurred a loss from operations of approximately $3.1 million for the nine months ended September 30, 2019. As of September 30, 2019, cash and
cash equivalents totaled approximately $4.2 million. While we anticipate that our current cash, cash equivalents, and cash to be generated from operations will be sufficient to meet our projected operating plans for the foreseeable future through at
least a year and a day from the issuance of these unaudited condensed consolidated financial statements, should we require additional funds (either through equity or debt financings, collaborative agreements or from other sources) we have no
commitments to obtain such additional financing, and we may not be able to obtain any such additional financing on terms favorable to us, or at all.
Basis of Presentation and Principles of Consolidation
The Company’s unaudited condensed consolidated financial statements are prepared in accordance with GAAP. The unaudited condensed consolidated financial
statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date.
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Healthy Choice Markets, Inc.,
Healthy Choice Markets 2, LLC (“Paradise Health and Nutrition”), The Vitamin Store, LLC, Healthy U Wholesale, Inc., The Vape Store, Inc. (“Vape Store”), Vaporin, Inc. (“Vaporin”), Smoke Anywhere U.S.A., Inc. (“Smoke”), Emagine the Vape Store, LLC
(“Emagine”), IVGI Acquisition, Inc., Vapormax Franchising LLC, Vaporin LLC, and Vaporin Florida, Inc. All intercompany accounts and transactions have been eliminated in consolidation.
6
Unaudited Interim Financial Information
The unaudited condensed consolidated financial statements have been prepared by the Company and reflect all normal, recurring adjustments that, in the
opinion of management, are necessary for a fair presentation of the interim financial information. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for any subsequent quarter or
for the year ending December 31, 2019. Certain information and footnotes normally included in financial statements prepared in accordance with GAAP have been omitted under the instructions to Form 10-Q and Article 10 of Regulation S-X of the
Securities and Exchange Commission (“SEC”). These unaudited condensed consolidated financial statements and notes included herein should be read in conjunction with the audited consolidated financial statements and related notes thereto as of and for
the year ended December 31, 2018 included in the Company’s Annual Report on Form 10-K for such year as filed with the SEC on March 27, 2019.
Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Reclassifications
Certain prior period amounts in the consolidated financial statements related to write-down of obsolete and slow moving inventory, due from merchant credit
card processors, gain (loss) on investment and other income (expense), net have been reclassified to conform to the current period’s presentation. No changes to the Company’s net loss were made as a result of such reclassifications.
Use of Estimates in the Preparation of the Financial Statements
The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods.
Actual results could differ from those estimates. These estimates and assumptions include allowances, reserves and write-downs of receivables and inventory, valuing equity securities and hybrid instruments, share-based payment arrangements, deferred
taxes and related valuation allowances, and the valuation of the assets and liabilities acquired in business combinations. Certain of management’s estimates could be affected by external conditions, including those unique to our industry, and general
economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on
these conditions and records adjustments when necessary.
Adopted Accounting Pronouncements
In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). ASU 2016-02 establishes a right-of-use (“ROU”) model that requires
a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in
the income statement. ASU 2016-02 is effective for annual periods beginning after December 15, 2018, and annual and interim periods thereafter, with early adoption permitted. The Company adopted ASU No. 2016-02 on January 1, 2019 using the
cumulative-effect adjustment transition method, which applies the provisions of the standard at the effective date without adjusting the comparative periods presented.
Adoption of this standard resulted in the recognition of operating lease right-of-use assets of $4,988,000 and corresponding lease liabilities of
$4,350,000 on the consolidated balance sheet as of January 1, 2019. An adjustment to Ada’s favorable lease of $739,000 and prepaid rent of $2,000, resulted in a cumulative effect adjustment of $103,000. The standard did not materially impact
operating results or liquidity. Disclosures related to the amount, timing and uncertainty of cash flows arising from leases are included in Note 10, Leases.
Note 3. CONCENTRATIONS
Cash
Our cash balances are kept liquid to support our growing acquisition and infrastructure needs for operational expansion. The majority of the Company’s cash
and cash equivalents are concentrated in one large financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage.
A summary of the financial institutions that had a cash and cash equivalents in excess of FDIC limits of $250,000 at September 30, 2019 and December 31,
2018 is presented below:
|
|
September 30,
2019
|
December 31,
2018
|
|||
|
Total Cash in excess of FDIC limits of $250,000
|
$
|
3,309,854
|
6,039,000
|
||
7
The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests, as deposits are held in
excess of federally insured limits. The Company has not experienced any losses in such accounts.
Vendor
We source from multiple suppliers. These suppliers range from small independent businesses to multinational conglomerates. For the nine months ended
September 30, 2019, we purchased approximately 68% of the goods we sell from our top 20 suppliers.
Purchase from one vendor in excess of 20% of total purchase is summarized in below table:
|
|
September 30,
2019
|
December 31,
2018
|
|||
|
Purchase in excess of 20% of total purchase
|
|||||
|
Vendor A
|
22%
|
30%
|
|||
Note 4. DISAGGREGATION OF REVENUES
The Company reports the following segments in accordance with management guidance: Vapor and Grocery. When the Company prepares its internal management
reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.
|
Three Months Ended
|
Nine Months Ended
|
||||||||||
|
September 30,
2019
|
September 30,
2018
|
September 30,
2019
|
September 30,
2018
|
||||||||
|
Vapor
|
$
|
898,229
|
$
|
1,106,596
|
$
|
3,207,530
|
$
|
3,556,130
|
|||
|
Grocery
|
2,520,101
|
1,923,878
|
8,407,919
|
6,359,671
|
|||||||
|
Total revenue
|
$
|
3,418,330
|
$
|
3,030,474
|
$
|
11,615,449
|
$
|
9,915,801
|
|||
|
Retail Vapor
|
$
|
898,216
|
$
|
1,106,228
|
$
|
3,207,120
|
$
|
3,548,704
|
|||
|
Retail Grocery
|
2,133,537
|
1,407,776
|
7,143,616
|
4,581,001
|
|||||||
|
Food service/restaurant
|
291,435
|
370,609
|
949,211
|
1,167,006
|
|||||||
|
Online/eCommerce
|
81,035
|
135,483
|
285,891
|
593,347
|
|||||||
|
Wholesale Grocery
|
14,094
|
10,010
|
29,201
|
18,317
|
|||||||
|
Wholesale Vapor
|
13
|
368
|
410
|
7,426
|
|||||||
|
Total revenue
|
$
|
3,418,330
|
$
|
3,030,474
|
$
|
11,615,449
|
$
|
9,915,801
|
|||
Note 5. INTANGIBLE ASSETS
Intangible assets, net are as follows:
|
September 30, 2019
|
Useful Lives (Years)
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Carrying Amount
|
||||||||
|
Trade names
|
8-10 years
|
$
|
993,000
|
$
|
(328,733)
|
$
|
664,267
|
|||||
|
Customer relationships
|
4-10 years
|
1,228,000
|
(230,198)
|
997,802
|
||||||||
|
Patents
|
10 years
|
270,250
|
(42,271)
|
227,979
|
||||||||
|
Non-compete
|
4 years
|
174,000
|
(34,438)
|
139,562
|
||||||||
|
Website
|
3 years
|
4,500
|
(4,500)
|
-
|
||||||||
|
Intangible assets, net
|
$
|
2,669,750
|
$
|
(640,140)
|
$
|
2,029,610
|
||||||
|
December 31, 2018
|
Useful Lives (Years)
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Carrying Amount
|
||||||||
|
Favorable lease
|
15 years
|
$
|
890,000
|
$
|
(150,580)
|
$
|
739,420
|
|||||
|
Trade names
|
8-10 years
|
993,000
|
(252,329)
|
740,671
|
||||||||
|
Customer relationships
|
4-10 years
|
1,228,000
|
(41,010)
|
1,186,990
|
||||||||
|
Patents
|
10 years
|
245,250
|
(22,940)
|
222,310
|
||||||||
|
Non-compete
|
4 years
|
174,000
|
(1,812)
|
172,188
|
||||||||
|
Website
|
3 years
|
4,500
|
(3,875)
|
625
|
||||||||
|
Intangible assets, net
|
$
|
3,534,750
|
$
|
(472,546)
|
$
|
3,062,204
|
||||||
8
Intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense amounted to approximately $318,000 and
$122,000 for the nine months ended September 30, 2019 and 2018, respectively. Due to adoption of ASU No. 2016-02 on January 1, 2019, the Company’s favorable lease intangible asset associated with its Ada’s Natural Market location, with a net balance
of $739,000 as of December 31, 2018, was reclassified to right-of-use asset in the Ada’s lease amortization schedule to correct the January 1, 2019 opening balance sheet. Future annual estimated amortization expense is as follows:
|
Years ending December 31,
|
||
|
2019 (remaining three months)
|
$
|
106,160
|
|
2020
|
424,650
|
|
|
2021
|
417,650
|
|
|
2022
|
402,270
|
|
|
2023
|
163,400
|
|
|
Thereafter
|
515,480
|
|
|
Total
|
$
|
2,029,610
|
Note 6. CONTRACT ASSETS AND CONTRACT LIABILITIES
The Company’s contract assets consist of sales commissions to third parties that support and facilitate the completion of complex transactions, for which
the Company has a performance obligation to pay due to the fact that the sales agreement was fully executed.
The Company’s deferred revenue consists of gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products when
customers redeem balances or terms expire through breakage. Our breakage policy is twenty four-month for gift cards, twelve months for Grocery loyalty rewards, and six months for Vapor loyalty rewards. As such, all contract liabilities are expected
to be recognized within a twenty four-month period. Revenue is recognized when gift card and loyalty points are redeemed.
A summary of the net changes in contract liabilities activity for the nine months ended September 30, 2019 and 2018 is presented below:
|
September 30,
2019
|
September 30,
2018
|
||||
|
Beginning balance as January 1,
|
$
|
442,630
|
$
|
61,312
|
|
|
Issued
|
50,778
|
81,720
|
|||
|
Redeemed
|
(57,319)
|
(113,954)
|
|||
|
Breakage recognized
|
(1,563)
|
916
|
|||
|
Fulfillment of contract
|
(260,198)
|
2,000,000
|
|||
|
Ending balance as of September 30,
|
$
|
174,328
|
$
|
2,029,994
|
|
Note 7. STOCKHOLDERS’ EQUITY
Series A Warrants
A summary of warrant activity for the nine months ended September 30, 2019 is presented below:
|
Exercise
Price
|
Warrant Common
Stock Equivalent
|
Remaining
Contractual Term
|
||||||
|
Outstanding at January 1, 2019
|
$
|
0.0001
|
41,643,000,000
|
1.50
|
||||
|
Warrants settlement
|
$
|
-
|
-
|
|||||
|
Cashless exercises for common stock
|
$
|
(0.0001)
|
(75,000,000)
|
|||||
|
Black Scholes Value adjustment
|
$
|
(0.0001)
|
(148,000,000)
|
|||||
|
Outstanding at September 30, 2019
|
$
|
0.0001
|
41,420,000,000
|
0.75
|
||||
Pursuant to the Series A Warrant agreement, the Black Scholes value is calculated by a third-party and utilized in calculating the warrant common stock
equivalents at the point of cashless exercise. As such, the value is computed at the end of each reporting period to determine the amount of warrant common stock equivalents outstanding using the formula below:
(Series A Warrants exercised * Black Scholes Value) / Closing common stock bid price as of two trading days prior.
9
A summary of the outstanding warrant common stock equivalents at September 30, 2019 and December 31, 2018 is presented below:
|
|
September 30,
2019
|
December 31,
2018
|
|||
|
Warrants outstanding
(A)
|
2.7299
|
2.7348
|
|||
|
Black Scholes value
(B)
|
1,517,280
|
1,522,692
|
|||
|
Subtotal
(C)=(A) x (B)
|
4,142,023
|
4,164,258
|
|||
|
Closing bid stock price
(D)
|
$
|
0.0001
|
$
|
0.0001
|
|
|
Warrant common stock equivalent
(C)/(D)
|
41,420,000,000
|
41,643,000,000
|
|||
Stock Options
The Company recognized stock-based compensation in connection with the amortization of stock options, net of recovery of stock-based charges for forfeited
unvested stock options. Stock-based compensation expense is included as part of operating expenses in the accompanying consolidated statements of operations.
A summary of Stock-based compensation expense recognized is presented below:
|
Three Months Ended
|
Nine Months Ended
|
||||||||||
|
September 30,
2019
|
September 30,
2018
|
September 30,
2019
|
September 30,
2018
|
||||||||
|
Stock-based compensation
|
$
|
147,570
|
$
|
140,356
|
$
|
343,824
|
$
|
1,298,862
|
|||
At September 30, 2019, the amount of unamortized stock-based compensation expense associated with unvested stock options granted to employees, directors
and consultants was approximately $73,000, which will be amortized over a weighted average period of 1 year.
Loss Per Share
Basic loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the period. Diluted
loss per share is computed using the weighted average number of shares of common stock outstanding and, if dilutive, potential shares of common stock outstanding during the period. Potential common shares consist of incremental shares of common stock
issuable upon (a) the exercise of stock options (using the treasury stock method); (b) the conversion of Series A convertible preferred stock; (c) the exercise of warrants (using the if-converted method); (d) the vesting of restricted stock units;
and (e) the conversion of convertible notes payable. Diluted income (loss) per share excludes the potential common shares, as their effect is antidilutive.
The following table summarizes the Company’s securities, in common share equivalents, that have been excluded from the calculation of dilutive loss per
share as their effect would be anti-dilutive:
|
|
September 30,
|
|||||||
|
2019
|
2018
|
|||||||
|
Preferred stock
|
201,501,000,000
|
201,501,000,000
|
||||||
|
Stock options
|
91,062,000,000
|
90,012,000,000
|
||||||
|
Warrants
|
41,420,000,000
|
44,369,000,000
|
||||||
|
Total
|
333,983,000,000
|
335,882,000,000
|
||||||
10
Note 8. FAIR VALUE MEASUREMENTS
The fair value framework under FASB’s guidance requires the categorization of assets and liabilities into three levels based upon the assumptions used to
measure the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3, if applicable, would generally require significant management judgment. The three levels for categorizing assets and liabilities under the
fair value measurement requirements are as follows:
| ● |
Level 1: Fair value measurement of the asset or liability using observable inputs such as quoted prices in active markets for identical assets or liabilities;
|
| ● |
Level 2: Fair value measurement of the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either
directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and
|
| ● |
Level 3: Fair value measurement of the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or
liability.
|
Nonfinancial assets such as goodwill, other intangible assets, and long-lived assets held and used are measured at fair value and tested for impairment
annually, or when there is an indicator of impairment between annual tests.
The following table summarizes the liabilities measured at fair value on a recurring basis as of September 30, 2019:
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||
|
LIABILITIES
|
|||||||||||
|
Derivative liabilities – warrants
|
$
|
-
|
$
|
1,719,816
|
$
|
-
|
$
|
1,719,816
|
|||
|
Total derivative liabilities – warrants
|
$
|
-
|
$
|
1,719,816
|
$
|
-
|
$
|
1,719,816
|
|||
The following table summarizes the liabilities measured at fair value on a recurring basis as of December 31, 2018:
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||
|
LIABILITIES
|
|||||||||||
|
Derivative liabilities – warrants
|
$
|
-
|
$
|
1,722,928
|
$
|
-
|
$
|
1,722,928
|
|||
|
Total derivative liabilities – warrants
|
$
|
-
|
$
|
1,722,928
|
$
|
-
|
$
|
1,722,928
|
|||
Note 9. COMMITMENTS AND CONTINGENCIES
Legal Proceedings
From time to time the Company may be involved in various claims and legal actions arising in the ordinary course of our business. With respect to legal
costs, we record such costs as incurred.
A subsidiary of the Company is a defendant in two lawsuits that stem from purported defect and negligence concerning electronic cigarette products it sold.
The action was filed in state court in Broward County, Florida. Plaintiff is seeking damages for his physical injuries as well as his pain and suffering. Plaintiff claims that he was injured by a vape battery explosion that occurred in his pocket on
or about September 2017 and that he purchased the battery from a store operated by the Company’s subsidiary.
The other lawsuit was filed in the 8th Judicial Circuit in and for Alachua Court, Florida. Plaintiff claimed that a battery explosion occurred in his
pocket on or about May 1, 2018. Plaintiff sued the Company, alleging design and manufacturing defects in the subject battery, as well as breach of warranties and negligence, which caused or contributed to the Plaintiff’s injuries and damages.
While discovery is ongoing, the Company intends to vigorously dispute these claims that have been asserted against it.
Note 10. LEASE
The Company has various lease agreements with terms up to 20 years, including leases of retail stores, headquarter and equipment. All the leases are
classified as operating leases. The Company adopted Accounting Standards Codification (“ASC”) 842, “Leases” (“ASC 842”) effective January 1, 2019 using the cumulative-effect adjustment transition method, which applies the provisions of the standard
at the effective date without adjusting the comparative periods presented. We elected not to reassess whether any expired or existing contracts are or contain leases, reassess the lease classification for any expired or existing leases, nor reassess
initial direct costs for any existing leases.
11
The standard had an impact on the Company’s condensed consolidated balance sheets, but did not have a material impact on the Company’s condensed
consolidated statements of operations or condensed consolidated statements of cash flows upon adoption. Upon adoption, the Company recognized right-of-use asset of $5.0 million and lease liability of $4.3 million for operating leases as of January 1,
2019.
The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s operating leases as of September
30, 2019.
|
Maturity of Lease Liabilities by Fiscal Year
|
||
|
2019 (remaining)
|
$
|
165,350
|
|
2020
|
633,636
|
|
|
2021
|
507,682
|
|
|
2022
|
464,380
|
|
|
2023
|
441,262
|
|
|
Thereafter
|
2,888,699
|
|
|
Total undiscounted operating lease payments
|
$
|
5,101,009
|
|
Less: Imputed interest
|
(1,154,238)
|
|
|
Present value of operating lease liabilities
|
$
|
3,946,771
|
|
Balance Sheet Classification
|
||
|
Operating lease liability, current
|
$
|
472,106
|
|
Operating lease liability, net of current
|
3,474,665
|
|
|
Total operating lease liabilities
|
$
|
3,946,771
|
|
Other Information
|
||||
|
Weighted-average remaining lease term for operating leases
|
11 years
|
|||
|
Weighted-average discount rate for operating leases
|
4.8
|
%
|
||
Components of lease cost are as follows:
|
September 30,
2019
|
||
|
Operating lease cost
|
$
|
380,901
|
|
Variable lease cost
|
238,996
|
|
|
Short-term lease cost
|
107,759
|
|
|
Total Rent Expense
|
$
|
727,656
|
Cash Flows
Cash paid for amounts included in the present value of operating lease liabilities was $403,000 for the nine months ended September 30, 2019 and was
included in operating cash flows. The amortization of the right-of-use asset of $460,000 was included in operating cash flows.
Supplemental balance sheet information related to our operating leases is as follows:
|
|
Balance Sheet Classification
|
January 1, 2019
|
September 30,
2019
|
||||||
|
Right of use asset
|
Other assets
|
$
|
4,988,227
|
$
|
4,528,468
|
||||
|
Lease liability, current
|
Current liabilities
|
$
|
553,316
|
$
|
472,106
|
||||
|
Lease liability, net of current
|
Other liabilities
|
$
|
3,796,312
|
$
|
3,474,665
|
||||
12
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF CONDENSED
CONSOLDIATED OPERATIONS
The following discussion and analysis should be read in conjunction with our unaudited interim condensed consolidated financial statements and related
notes appearing elsewhere in this report on Form 10-Q. In addition to historical information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties, and assumptions. Our actual results may differ
materially from those anticipated in these forward-looking statements. The terms “we,” “us,” “our,” and the “Company” refer to Healthier Choices Management Corp. and its wholly-owned subsidiaries, Healthy Choice Markets, Inc., Healthy Choice Markets
2, LLC (“Paradise Health and Nutrition”), The Vitamin Store, LLC, Healthy U Wholesale, Inc., The Vape Store, Inc. (“Vape Store”), Vaporin, Inc. (“Vaporin”), Smoke Anywhere U.S.A., Inc. (“Smoke”), Emagine the Vape Store, LLC (“Emagine”), IVGI
Acquisition, Inc., Vapormax Franchising LLC, Vaporin LLC, and Vaporin Florida, Inc. . All intercompany accounts and transactions have been eliminated in consolidation.
Company Overview
Healthier Choices Management Corp. (the “Company”) is a holding company focused
on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The Company currently operates nine retail vape stores in the Southeast region of the United States, through which it offers e-liquids,
vaporizers and related products. The Company markets its Q-Cup™ technology under the vape segment. This Q-Cup™ technology provides significantly more efficiency and an “on the go” solution for consumers who prefer to vape concentrates either
medicinally or recreationally.
In October 2019, the Company announced the launch of the Q-Unit, a U.S. patented device made specifically for vaping concentrates. The Q-Unit, which boasts a mechanism that prevents the concentrates from
coming in direct contact with the heating element, allows consumers to vape uncut pure extract from a pure quartz cup.
The Company also operates Ada’s Natural Market, a
natural and organic grocery store, through its wholly owned subsidiary Healthy Choice Markets, Inc. and Paradise Health and Nutrition, stores that offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood,
deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items through its wholly owned subsidiary Healthy Choice Markets 2, LLC.
Liquidity
The unaudited condensed consolidated financial statements included elsewhere in this Form 10-Q have been prepared in conformity with GAAP, which
contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related
to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The unaudited consolidated financial statements do not
include any adjustments that might result from the outcome of these uncertainties.
The Company incurred a loss from operations of approximately $3.1 million for the nine months ended September 30, 2019. As of September 30, 2019, cash and
cash equivalents totaled approximately $4.2 million. While we anticipate that our current cash, cash equivalents, and cash to be generated from operations will be sufficient to meet our projected operating plans for the foreseeable future through a
year and a day from the issuance of these unaudited consolidated financial statements, should we require additional funds (either through equity or debt financings, collaborative agreements or from other sources) we have no commitments to obtain such
additional financing, and we may not be able to obtain any such additional financing on terms favorable to us, or at all. If adequate financing is not available, the Company will further delay, postpone or terminate product and service expansion and
curtail certain selling, general and administrative operations. The inability to raise additional financing may have a material adverse effect on the future performance of the Company.
Factors Affecting Our Performance
We believe the following factors affect our performance:
Vapor Retail
: We believe the
operating performance of our vapor retail stores will affect our revenue and financial performance. The Company has a total of nine retail vape stores, which are located in Florida, Georgia and Tennessee.
Inventory Management
: Our vapor
segment revenue trends are affected by an evolving product acceptance and consumer demand. We are creating and offering new products to our retail vapor customers. Evolving product development and technology impacts our licensing and intellectual
properties spending. We expect the transition to vaporizer and advanced technology and enhanced performance products to continue and will impact our overall operating results in the future.
Increased Competition
: The launch
by national competitors in both of our business reporting segments have made it more difficult to compete on prices and to secure business. We expect increased product supply and downward pressure on prices to continue and impact our operating
results in the future. We also expect the continued expansion of national grocery chains, which leads to greater competition, to impact our operating results in the future.
13
Results of Operations
The following table sets forth our unaudited condensed consolidated Statements of Operations for the three months ended September 30, 2019 and 2018 that is
used in the following discussions of our results of operations:
|
Three Months Ended September 30,
|
2019 to 2018
|
|||||||
|
2019
|
2018
|
Change $
|
||||||
|
SALES
|
||||||||
|
Vapor sales, net
|
$
|
898,229
|
$
|
1,106,596
|
$
|
(208,367)
|
||
|
Grocery sales, net
|
2,520,101
|
1,923,878
|
596,223
|
|||||
|
TOTAL SALES, NET
|
3,418,330
|
3,030,474
|
387,856
|
|||||
|
Cost of sales vapor
|
385,208
|
460,648
|
(75,440)
|
|||||
|
Cost of sales grocery
|
1,629,980
|
1,183,033
|
446,947
|
|||||
|
GROSS PROFIT
|
1,403,142
|
1,386,793
|
16,349
|
|||||
|
OPERATING EXPENSES
|
||||||||
|
Advertising
|
46,190
|
56,021
|
(9,831)
|
|||||
|
Selling, general and administrative
|
2,486,315
|
2,123,471
|
362,844
|
|||||
|
Total operating expenses
|
2,532,505
|
2,179,492
|
353,013
|
|||||
|
LOSS FROM OPERATIONS
|
(1,129,363)
|
(792,699)
|
(336,664)
|
|||||
|
OTHER INCOME (EXPENSE)
|
||||||||
|
Loss on repurchase of Series A warrants
|
-
|
(10,696,774)
|
(10,696,774)
|
|||||
|
Gain (loss) on investment
|
(12,514)
|
11,999
|
(24,513)
|
|||||
|
Other income (expense)
|
(146)
|
152,260
|
(152,406)
|
|||||
|
Interest income (expense)
|
(8,280)
|
30,458
|
(38,738)
|
|||||
|
Total other income (expense), net
|
(20,940)
|
(10,502,057)
|
10,481,117
|
|||||
|
NET LOSS
|
$
|
(1,150,303)
|
$
|
(11,294,756)
|
$
|
10,144,453
|
||
Net Vapor sales decreased $0.2 million to $0.9 million for the three months ended September 30, 2019 as compared to $1.1 million for the same period in
2018. The decrease in sales is primarily due to the decreased number of stores – nine stores open during the three months ended September 30, 2019 as compared to twelve retail stores and one wholesale location for the same period in 2018.
Net Grocery sales increased $0.6 million to $2.5 million for the three months ended September 30, 2019 as compared to $1.9 million for the same period in
2018. The increase in sales is primarily due to the acquisition of three Paradise Health and Nutrition stores.
Vapor cost of goods sold for the three months ended September 30, 2019 and 2018 were $0.4 million and $0.5 million, respectively, a decreased of $0.1
million. The decrease is primarily due to decreases in product costs during three months ended September 30, 2019 as compared to the same period in 2018. Gross profit was $0.5 million and $0.6 million for three months ended September 30, 2019 and
2018, respectively.
Grocery cost of goods sold for the three months ended September 30, 2019 and 2018 were $1.6 million and $1.2 million respectively, an increase increasedof
$0.4 million. The increase is primarily due to increases in sales and cost of goods sold from the acquisition of three Paradise Health and Nutrition stores. Gross profit was $0.9 million and $0.7 million for the three months ended September 30, 2019
and 2018, respectively.
Selling, general and administrative expenses increased $0.4 million to $2.5 million for the three months ended September 30, 2019 compared to $2.1 million
for the same period in 2018. The increase is primarily attributable to increases in payroll and employee related cost of $0.2 million, occupancy costs of $0.1 million, and depreciation and amortization of $0.1 million.
Net other expense of $21,000 for the three months ended September 30, 2019
includes loss on investment of $13,000, and interest expense of $8,000. Net other expense of $10.5 million for the three months ended September 30, 2018 includes a
change in fair value of Series A Warrants of
$10.7 million,
offset by other income of $0.2 million, interest income of $30,000, and gain on investment of $12,000
.
14
The following table sets forth our unaudited consolidated Statements of Operations for the nine months ended September 30, 2019 and 2018 that is used in
the following discussions of our results of operations:
|
Nine Months Ended
September 30,
|
2019 to 2018
|
|||||||
|
2019
|
2018
|
Change $
|
||||||
|
SALES
|
||||||||
|
Vapor sales, net
|
$
|
3,207,530
|
$
|
3,556,130
|
$
|
(348,600)
|
||
|
Grocery sales, net
|
8,407,919
|
6,359,671
|
2,048,248
|
|||||
|
TOTAL SALES, NET
|
11,615,449
|
9,915,801
|
1,699,648
|
|||||
|
Cost of sales vapor
|
1,337,555
|
1,602,363
|
(264,808)
|
|||||
|
Cost of sales grocery
|
5,309,567
|
3,850,998
|
1,458,569
|
|||||
|
GROSS PROFIT
|
4,968,327
|
4,462,440
|
505,887
|
|||||
|
OPERATING EXPENSES
|
||||||||
|
Advertising
|
135,794
|
137,485
|
(1,691)
|
|||||
|
Selling, general and administrative
|
7,921,658
|
7,196,680
|
724,978
|
|||||
|
Total operating expenses
|
8,057,452
|
7,334,165
|
723,287
|
|||||
|
LOSS FROM OPERATIONS
|
(3,089,125)
|
(2,871,725)
|
(217,400)
|
|||||
|
OTHER INCOME (EXPENSE)
|
||||||||
|
Loss on repurchase of Series A warrants
|
-
|
(10,696,774)
|
10,696,774
|
|||||
|
Gain (loss) on investment
|
(57,514)
|
11,999
|
(69,513)
|
|||||
|
Other income (expense)
|
(838)
|
469,760
|
(470,598)
|
|||||
|
Interest income (expense)
|
(19,669)
|
63,219
|
(82,888)
|
|||||
|
Total other income (expense), net
|
(78,021)
|
(10,151,796)
|
10,073,775
|
|||||
|
NET LOSS
|
$
|
(3,167,146)
|
$
|
(13,023,521)
|
$
|
9,856,375
|
||
Net Vapor sales decreased $0.3 million to $3.2 million for the nine months ended September 30, 2019 as compared to $3.6 million for the same period in
2018. The decrease in sales is primarily due to nine stores open during the nine months ended September 30, 2019 as compared to twelve retail stores and one wholesale location for the same period in 2018.
Net Grocery sales increased $2.0 million to $8.4 million for the nine months ended September 30, 2019 as compared to $6.4 million for the same period in
2018. The increase in sales is primarily due to the acquisition of three Paradise Health and Nutrition stores.
Vapor cost of goods sold for the nine months ended September 30, 2019 and 2018 were $1.3 million and $1.6 million, respectively, a decrease of $0.3
million. The decrease is primarily due to the decreased number of stores. Gross profit was $1.9 million and $2.0 million for the nine months ended September 30, 2019 and 2018, respectively.
Grocery cost of goods sold for the nine months ended September 30, 2019 and 2018 were $5.3 million and $3.9 million, respectively, an increase of $1.5
million. The increase is primarily due to increases in sales and cost of goods sold from the acquisition of three Paradise Health and Nutrition stores. Gross profit was $3.1 million and $2.5 million for the nine months ended September 30, 2018 and
2018, respectively.
Selling, general and administrative expenses increased $0.7 million to $7.9 million for the nine months ended September 30, 2019 compared to $7.2 million
for the same period in 2018. The increase is primarily attributable to increases in payroll and employee related cost of $0.9 million, occupancy costs of $0.3 million, depreciation and amortization of $0.2 million, and taxes, licenses & permits
of $0.1 million, and insurance costs of $0.1 million, offset by a decrease in stock-based compensation of $1.0 million.
Net other expense of $0.1 million for the nine months ended September 30, 2019
was primarily due to a loss on investment of $0.1 million. Net other expense of $10.2 million for the nine months ended September 30, 2018 includes
a change in fair value of Series A Warrants of $10.7 million, offset by other income of $0.5
million, and interest income of $0.1 million.
The company did not incur activity from discontinued operations for the nine months ended September 30, 2019 or for the same period in 2018.
15
Liquidity and Capital Resources
|
Nine Months Ended
September 30
,
|
|||||
|
2019
|
2018
|
||||
|
Net cash used in operating activities
|
$
|
(2,854,769)
|
$
|
393,916
|
|
|
Net cash provided by investing activities
|
99,283
|
(581,936)
|
|||
|
Net cash provided by financing activities
|
(56,783)
|
576,205
|
|||
|
$
|
(2,812,269)
|
$
|
388,185
|
||
Our net cash used in operating activities of $2.9 million for the nine months
ended September 30, 2019 resulted from our net loss of $3.2 million, a net cash usage of $1.0 million from changes in operating assets and liabilities, offset by amortization of rigth-of-used asset of $0.5 million, depreciation and amortization
expenses of $0.4 million and share-based compensation expense of $0.3 million. Our net cash used in operating activities of $0.4 million for the nine months ended September 30, 2018 resulted from
a non-cash adjustment of $12.2 million, and a
net cash usage of $1.2 million from changes in operating assets and liabilities, offset by a net loss of $13 million.
The net cash provided by investing activities of $0.1 million for the nine
months ended September 30, 2019 resulted from payments received on the VPR Brands L.P. Note. The net cash used in investing activities of $0.6 million for the nine months ended September 30, 2018
resulted from the issuance and collection of
a note receivable, and purchases of a patent and property and equipment
.
The net cash used in financing activities of $0.1 million for the nine months
ended September 30, 2019 resulted from $0.1 million proceeds from the credit line with Professional Bank, offset by $0.2 million of loan principle payment. The net cash provided by financing activities of $0.6 million for the nine months ended
September 30, 2018
is due to proceeds from loan payable of $0.5 million and proceeds from exercise of stock options of $0.1 million
.
At September 30, 2019 and December 31, 2018, we did not have any material financial guarantees or other contractual commitments with vendors that are
reasonably likely to have an adverse effect on liquidity.
Our cash balances are kept liquid to support our growing acquisition and infrastructure needs for operational expansion. The majority of our cash and cash
equivalents are concentrated in three financial institutions and are generally in excess of the FDIC insurance limit. The Company has not experienced any losses on its cash and cash equivalents. The following table presents the Company’s cash
position as of September 30, 2019 and December 31, 2018.
|
September 30,
2019
|
December 31,
2018
|
||||
|
Cash
|
$
|
4,248,984
|
$
|
7,061,253
|
|
|
Total assets
|
$
|
15,417,891
|
$
|
15,172,663
|
|
|
Percentage of total assets
|
27.56%
|
46.54%
|
|||
The Company reported a net loss of $3.2 million for the nine months ended September 30, 2019. The Company also had positive working capital of $1.0
million. The Company expects to continue incurring losses for the foreseeable future and may need to raise additional capital to satisfy warrant obligations, and to continue as a going concern.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements.
Critical Accounting Policies and Estimates
Our management’s discussion and analysis of financial condition and results of operations is based on our consolidated financial statements, which have
been prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. The preparation of these consolidated financial statements requires us to exercise considerable judgment with respect to establishing sound
accounting policies and in making estimates and assumptions that affect the reported amounts of our assets and liabilities, our recognition of revenues and expenses, and disclosure of commitments and contingencies at the date of the consolidated
financial statements.
16
We base our estimates on our historical experience, knowledge of our business and industry, current and expected economic conditions, the attributes of our
products, the regulatory environment, and in certain cases, the results of outside appraisals. We periodically re-evaluate our estimates and assumptions with respect to these judgments and modify our approach when circumstances indicate that
modifications are necessary. These estimates and assumptions form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.
While we believe that the factors we evaluate provide us with a meaningful basis for establishing and applying sound accounting policies, we cannot
guarantee that the results will always be accurate. Since the determination of these estimates requires the exercise of judgment, actual results could differ from such estimates.
There have been no material changes to the Company’s critical accounting policies and estimates as compared to the critical accounting policies and
estimates described in the 2018 Annual Report, which we believe are the most critical to our business and the understanding of our results of operations and affect the more significant judgments and estimates that we use in the preparation of our
consolidated financial statements.
Seasonality
We do not consider our business to be seasonal.
Cautionary Note Regarding Forward-Looking Statements
This report includes forward-looking statements including statements regarding retail expansion, the future demand for our products, the transition to
vaporizer and other products, competition, the adequacy of our cash resources and our authorized Common Stock, and our continued ability to raise capital.
The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect”
and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we
believe may affect our financial condition, results of operations, business strategy and financial needs.
The results anticipated by any or all of these forward-looking statements might not occur. Important factors that could cause actual results to differ from
those in the forward-looking statements include our future common stock price, the timing of future warrant exercises and stock sales, having the authorized capital to issue stock to exercising Series A Warrant holders, customer acceptance of our
products, and proposed federal and state regulation. We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise.
17
Not applicable to smaller reporting companies.
Evaluation of Disclosure Controls and Procedures
Our management, including our Principal Executive Officer and Principal Financial Officer, did not carry out an evaluation on internal controls as of
September 30, 2019 in regard to the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, or the Exchange Act. As an evaluation was not carried out, our Principal
Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were ineffective as of the end of the period covered by this report.
In planning and performing its audit of our financial statements for the year ended December 31, 2018 in accordance with standards of the Public Company
Accounting Oversight Board, our independent registered public accounting firm noted material weaknesses in internal control over financial reporting. A list of our material weaknesses are as follows:
| ● |
Failure to have properly documented and designed disclosure controls and procedures and testing of the operating effectiveness of our internal control over
financial reporting
|
| ● |
Weakness around our inventory count procedures
|
| ● |
Segregation of duties due to lack of personnel
|
Our management concluded that considering internal control deficiencies that, in the aggregate, rise to the level of material weaknesses, we did not
maintain effective internal control over financial reporting as of September 30, 2019 based on the criteria set forth in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission
(“COSO”).
Changes in Internal Control over Financial Reporting
Following this assessment and during the nine months ended September 30, 2019, we have undertaken an action plan to
strengthen internal controls and procedures:
| ● |
We continue to improve the process around inventory counts and throughout the current year, we performed a blind-count for 75% of our overall inventory value with
the purpose of validating our inventory records and increasing the staff knowledge around the importance of the new inventory procedures implemented. In addition, we had an independent third-party count over 50% of our inventory value
conducted on September 30, 2019.
|
| ● |
Our management has increased its focus on the Company’s purchase order process in order to better manage inventory thereby improving cash management and ultimately
leading to more reliable and precise financial reporting.
|
Our management continues to review ways in which we can make improvements in internal control over financial reporting.
18
From time to time the Company may be involved in various claims and legal actions arising in the ordinary course of our business. We do not have any legal
proceedings which have a material impact to the financial statements as of September 30, 2019.
A subsidiary of the Company is a defendant in two lawsuits that stem from purported defect and negligence concerning electronic cigarette products it sold.
The action was filed in state court in Broward County, Florida. Plaintiff is seeking damages for his physical injuries as well as his pain and suffering. Plaintiff claims that he was injured by a vape battery explosion that occurred in his pocket on
or about September 2017 and that he purchased the battery from a store operated by the Company’s subsidiary.
The other lawsuit was filed in the 8th Judicial Circuit in and for Alachua Court, Florida. Plaintiff claimed that a battery explosion occurred in his
pocket on or about May 1, 2018. Plaintiff sued the Company, alleging design and manufacturing defects in the subject battery, as well as breach of warranties and negligence, which caused or contributed to the Plaintiff’s injuries and damages.
While discovery is at its infancy, the Company intends to vigorously dispute these claims that have been asserted against it.
Not Applicable.
None.
None.
Not Applicable.
Not Applicable.
See the exhibits listed in the accompanying “Index to Exhibits.”
19
INDEX TO EXHIBITS
|
Exhibit
|
Incorporated by Reference
|
Filed or Furnished
|
||||||||
|
No.
|
Exhibit Description
|
Form
|
Date
|
Number
|
Herewith
|
|||||
|
31.1
|
Filed
|
|||||||||
|
31.2
|
Filed
|
|||||||||
|
32.1
|
Furnished *
|
|||||||||
|
32.2
|
Furnished *
|
|||||||||
|
101.INS
|
XBRL Instance Document
|
Filed
|
||||||||
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
Filed
|
||||||||
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
Filed
|
||||||||
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
Filed
|
||||||||
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
Filed
|
||||||||
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
Filed
|
||||||||
| * |
This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.
|
20
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
|
HEALTHIER CHOICES MANAGEMENT CORP.
|
||
|
Date: October 29, 2019
|
By:
|
/s/ Jeffrey Holman
|
|
Jeffrey Holman
|
||
|
Chief Executive Officer
|
||
|
Date: October 29, 2019
|
By:
|
/s/ John Ollet
|
|
John Ollet
|
||
|
Chief Financial Officer
|
||
21
TABLE OF CONTENTS
Part I - Financial InformationItem 1. Financial Statements (unaudited)Note 1. Organization, Going Concern, and Basis Of PresentationNote 2. Summary Of Significant Accounting PoliciesNote 3. ConcentrationsNote 4. Disaggregation Of RevenuesNote 5. Intangible AssetsNote 6. Contract Assets and Contract LiabilitiesNote 7. Stockholders Equity Series A WarrantsNote 7. Stockholders EquityNote 8. Fair Value MeasurementsNote 9. Commitments and ContingenciesNote 10. LeaseItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of Condensed Consoldiated OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II - Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits